About
Titles
Staff Affiliate - VAMC
Departments & Organizations
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kathleen McGinnis's published research.
E. Jennifer Edelman, MD, MHS, BS
Kirsha Gordon, PhD, MS
Lamia Y. K. Haque, MD, MPH
Ronald George Hauser III, MD
Christopher T Rentsch, PhD, FISPE
David Fiellin, MD
Publications
2025
Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV
Wrona A, Justice A, Tate J, Rentsch C, Gordon K, Kidwai-Khan F, Silverberg M, Satre D, Marconi V, Ingle S, Sterne J, Cavassini M, Bryant K, McGinnis K. Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV. Cannabis 2025, 8: 177-190. PMID: 39968492, PMCID: PMC11831903, DOI: 10.26828/cannabis/2025/000269.Peer-Reviewed Original ResearchConceptsCannabis useKaiser Permanente Northern CaliforniaSwiss HIV Cohort StudyHIV Symptom IndexSelf-reportBothersome symptomsSubstance useAssociations of self-reportedBothersome levelSelf-reported substanceMental health symptomsSymptom IndexSelf-reported informationHIV Cohort StudyPatterns of associationWeight lossPresence/absence of symptomsCross-cohort studyLogistic regression modelsHealth symptomsCannabisHealth outcomesLoss of appetiteHIV cohortStudy HIVCorrigendum: Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration
McGinnis K, Justice A, Marconi V, Rodriguez-Barradas M, Hauser R, Oursler K, Brown S, Bryant K, Tate J. Corrigendum: Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration. Frontiers In Medicine 2025, 11: 1532350. PMID: 39845833, PMCID: PMC11750659, DOI: 10.3389/fmed.2024.1532350.Peer-Reviewed Original ResearchHarmonization of alcohol use data and mortality across a multi‐national HIV cohort collaboration
Ingle S, Trickey A, Lankina A, McGinnis K, Justice A, Cavassini M, Monforte A, van Sighem A, Gill M, Crane H, Obel N, Jarrin I, Wallner E, Guest J, Silverberg M, Vourli G, Wittkop L, Sterling T, Satre D, Burkholder G, Costagliola D, Sterne J. Harmonization of alcohol use data and mortality across a multi‐national HIV cohort collaboration. Alcohol Clinical And Experimental Research 2025, 49: 407-417. PMID: 39779221, PMCID: PMC11828971, DOI: 10.1111/acer.15522.Peer-Reviewed Original ResearchConceptsAUDIT-CAlcohol useAlcohol use dataCohort CollaborationAlcohol Use Disorders Identification TestAssociation of alcohol useAntiretroviral Therapy Cohort CollaborationNo alcohol useDisorders Identification TestJ-shaped relationshipEffects of alcohol useStudy of peopleMeasures of alcohol useHIV Cohort StudyHeavy alcohol useMeasure alcohol useAUDIT-C.Estimate associationsStandard drinksAdult PWHWhite ethnicityCohort studyHigher mortalityItem 1PWH
2024
The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD
Chandran A, Feng X, Coburn S, Kasaie P, Malone J, Horberg M, Hogan B, Rebeiro P, Gill M, McGinnis K, Silverberg M, Karris M, Napravnik S, Konkle-Parker D, Lee J, Freeman A, Ghidey R, Garza V, Marconi V, Kirk G, Thorne J, Crane H, Lang R, Kitahata M, Moore R, Althoff K. The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2024, 97: 232-241. PMID: 39431507, PMCID: PMC11494146, DOI: 10.1097/qai.0000000000003486.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsAssociated with viral suppressionSES indicatorsSocioeconomic statusOdds of viral suppressionNA-ACCORDRacial disparitiesImpact of social determinants of healthIndividual-level socioeconomic statusViral suppressionSocial determinants of healthNon-Hispanic white participantsDeterminants of healthSocioeconomic status factorsNon-Hispanic blacksAssociation of raceAttenuate racial disparitiesMultivariate logistic regression modelCross-sectional analysisCohort of PWHLogistic regression modelsSES informationInfluence well-beingDecreased oddsLow-incomeWhite participantsUsing Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.
Murnane P, Afshar M, Chamie G, Cook R, Ferguson T, Haque L, Jacobson K, Justice A, Kim T, Khalili M, Krupitsky E, McGinnis K, Molina P, Muyindike W, Myers B, Richards V, So-Armah K, Stewart S, Sulkowski M, Tien P, Hahn J. Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk. The American Journal Of Gastroenterology 2024 PMID: 39480054, DOI: 10.14309/ajg.0000000000003178.Peer-Reviewed Original ResearchConceptsLiver fibrosis riskAUDIT-CFIB-4Self-reported alcohol useOdds ratioAlcohol useFibrosis riskPooled individual-level dataLiver fibrosis preventionBody mass indexAssessment of alcohol useManagement of liver diseaseOne-unit differenceIndividual-level dataMedian ageAUDIT-C.Mass indexSuppression statusLiver diseaseFibrosis preventionBlood concentrationsAdjusted modelsLogistic regressionCategorical variablesHIVPain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Miller E, McGinnis K, Edelman E, Feinberg T, Gordon K, Kerns R, Marshall B, Patterson J, McRae M. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV. AIDS And Behavior 2024, 28: 3994-4004. PMID: 39264485, PMCID: PMC11586311, DOI: 10.1007/s10461-024-04494-w.Peer-Reviewed Original ResearchConceptsMental health classesSubstance use disordersOpioid use disorderHIV statusBuprenorphine initiationVeterans Aging Cohort StudyInitiate buprenorphineMental health diagnosesAging Cohort StudyBuprenorphine treatmentMultiple pain conditionsAssociated with HIV statusInfluence treatment retentionUse disorderTreatment of opioid use disorderHigher comorbidity burdenAge of patientsClinical encountersMental healthHealth diagnosisBlack veteransHealth classesLatent class analysisCohort studyPrescription dataEvaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation
Lang R, Coburn S, Gill M, Justice A, Grossman J, Gebo K, Horberg M, Mayor A, Silverberg M, McGinnis K, Hogan B, Moore R, Althoff K. Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation. AIDS Research And Therapy 2024, 21: 52. PMID: 39113038, PMCID: PMC11304803, DOI: 10.1186/s12981-024-00641-4.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsAntiretroviral therapy initiationAntiretroviral therapyNormocytic anemiaMicrocytic anemiaMean corpuscular volumeRisk factorsMacrocytic anemiaAssociated with increased morbidityCausative factors of anemiaProportion of PWHFactors of anemiaAssociated with increasing ageClassification of anemiaIdentified risk factorsAnemic peopleCD4 countHIV factorsNA-ACCORDLow hemoglobinAnemiaPWHEstimate crudeRobust varianceHemoglobin measurementsHIVCOVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration
Soyer E, McGinnis K, Justice A, Hsieh E, Rodriguez-Barradas M, Williams E, Park L. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. AIDS And Behavior 2024, 28: 3605-3614. PMID: 39046612, DOI: 10.1007/s10461-024-04449-1.Peer-Reviewed Original ResearchConceptsHIV statusSubstance use disordersBreakthrough infectionRisk of breakthroughAssociated with increased riskCOVID-19 breakthrough infectionsSARS-CoV-2Association of substance useSARS-CoV-2 infectionHIV treatment adherenceCD4 countHIV progressionSubstance useUnited States Veterans Health AdministrationHazard ratioIncreased riskPWHCD4PWoHHIVUse disorderVaccinated personsCohort of peopleTreatment adherenceLongitudinal cohortW31 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis
Haque L, Fiellin D, Bryant K, Edelman E, Justice A, Lim J, Re V, Marshall B, Taddei T, Tate J, Tetrault J, Williams E, McGinnis K. W31 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis. Drug And Alcohol Dependence 2024, 260: 110649. DOI: 10.1016/j.drugalcdep.2023.110649.Peer-Reviewed Original ResearchDiscrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America
Ambia J, Ingle S, McGinnis K, Pantazis N, Silverberg M, Wittkop L, Kusejko K, Crane H, van Sighem A, Sarcletti M, Cozzi-Lepri A, Domingo P, Jarrin I, Wyen C, Hessamfar M, Zhang L, Cavassini M, Berenguer J, Sterling T, Reiss P, Abgrall S, Gill M, Justice A, Sterne J, Trickey A. Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America. Open Forum Infectious Diseases 2024, 11: ofae333. PMID: 39015347, PMCID: PMC11249920, DOI: 10.1093/ofid/ofae333.Peer-Reviewed Original ResearchConceptsVeterans Aging Cohort StudyVeterans Aging Cohort Study IndexCause-specific mortalityNon-AIDS-defining cancersNon-AIDS-definingPredicting cause-specific mortalityFlexible parametric survival modelsAntiretroviral therapyC-statisticNon-AIDS infectionsAging Cohort StudyAbsolute mortality riskHarrell's C-statisticAntiretroviral therapy initiationParametric survival modelsTargeted careCause of deathMortality riskVisit dateMultiple imputationCohort studyPWHAssess discriminationCox modelRespiratory-related